Realcan Pharmaceutical Group News and Activities

Realcan Pharmaceutical Group is a company listed under the stock ticker 002589 (CN).

View the org chart displaying its 10 main executives

Most searched biographies at Realcan Pharmaceutical Group

• Xu Han, Chairman of the Board and President
• Xijun Liu, Independent Director
• Bo Yang, Director

Create your alert
to follow the executive moves at Realcan Pharmaceutical Group.

Realcan Pharmaceutical Group has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Jonathan Leff - Director at Larimar Therapeutics

Learn more about the Pharmaceuticals industry

Press releases by Realcan Pharmaceutical Group

Social media about Realcan Pharmaceutical Group

• Realcan Pharmaceutical Group on Wikipedia, Google News & Yahoo Finance
• Realcan Pharmaceutical Group on LinkedIn, X (Twitter) & YouTube